SeaSpine Posts 2Q17 Revenue
SeaSpine announced 2Q17 revenue of US $34.2MM, +3.0% vs. 2Q16, and 1H17 revenue of $66.1MM, +2.3% vs. 1H16....
Aug 07, 2017,
SeaSpine Posts 2Q17 Revenue
Wright Medical 2Q17 Revenue
Wright Medical reported 2Q17 revenue of US $179.7MM, +5.3% from 2Q16, and 1H17 revenue of $356.9MM, +5.0% vs. 1H16....
Aug 07, 2017, Julie Vetalice
DePuy Synthes to Co-market Surgical Impactor for Total Hip Arthroplasty
DePuy Synthes gained exclusive rights to co-market Medical Enterprises’ ME1000™ Surgical Impactor for use in Total Hip Arthroplasty....
Aug 07, 2017, Julie Vetalice
MiMedx Files for Achilles Tendonitis IND Phase III Clinical Trial
MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® Injectable to saline placebo in the treatment of Achilles Tendonitis....
Aug 07, 2017, Julie Vetalice
SurGenTec GRAFTGUN Receives U.S. Patent for Post-Filling Cages
SurGenTec was issued a U.S. patent protecting its Graftgun® bone graft loading technology used to post-fill all types of implantable cages in situ,...
Aug 04, 2017, Julie Vetalice
Smith & Nephew 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Smith & Nephew 2Q17 orthopaedic revenue of US $834.0MM, +1.1% from 2Q16, and 1H17 revenue of $1,660.9MM, +2.0%...
Aug 04, 2017, Julie Vetalice
K2M 2Q17 Revenue
K2M posted 2Q17 revenue of US $65.7MM, +10.9% vs. 2Q16, and 1H17 revenue of $127.6MM, +10.4% vs. 1H16....
Aug 04, 2017, Julie Vetalice
OrthoPediatrics Launches Pediatric-Specific Clavicle Plates
OrthoPediatrics launched PediFrag™, a pre-contoured pediatric-specific clavicle plate for the treatment of mid-shaft fractures....
Aug 04, 2017, Julie Vetalice
K2M Acquires Expandable Interbody IP Portfolio
K2M acquired exclusive license to a portfolio of 17 issued and pending patents for expandable interbody technology....
Aug 03, 2017, Julie Vetalice
Mazor Robotics 2Q17 Revenue Up 87% Year Over Year
Mazor Robotics reported 2Q17 revenue of US $15.5MM, +86.7% from 2Q16, and 1H17 revenue of $27.2MM, +85.0% vs. 1H16....
Aug 03, 2017, Julie Vetalice
Loading new posts...
No more posts
